Balyasny Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $647K | Buy |
+9,916
| New | +$647K | ﹤0.01% | 1492 |
|
|
2025
Q1 | – | Sell |
-38,488
| Closed | -$2.14M | – | 1992 |
|
|
2024
Q4 | $2.14M | Buy |
+38,488
| New | +$2.14M | ﹤0.01% | 1086 |
|
|
2024
Q3 | – | Sell |
-12,039
| Closed | -$767K | – | 1935 |
|
|
2024
Q2 | $767K | Buy |
+12,039
| New | +$767K | ﹤0.01% | 1320 |
|
|
2024
Q1 | – | Sell |
-5,311
| Closed | -$293K | – | 1960 |
|
|
2023
Q4 | $293K | Buy |
+5,311
| New | +$293K | ﹤0.01% | 1621 |
|
|
2022
Q4 | – | Sell |
-138,949
| Closed | -$4.47M | – | 2306 |
|
|
2022
Q3 | $4.47M | Buy |
+138,949
| New | +$4.47M | 0.01% | 806 |
|
|
2015
Q3 | – | Sell |
-7,730
| Closed | -$480K | – | 966 |
|
|
2015
Q2 | $480K | Buy |
+7,730
| New | +$480K | ﹤0.01% | 634 |
|